Recalls & Warnings March 23, 2026 FDA Warns Consumers Not to Use ULTRA ADVANC3 Joint Supplements On February 26, 2026, the FDA warned consumers not to purchase or use ULTRA ADVANC3 and ULTRA ADVANC3 GOLD, products promoted for joint pain relief, because FDA testing found that they contain undeclared dexamethasone, diclofenac, and methocarbamol, which are not permitted in
Many clients in The Colony and Frisco, TX, report feeling more alert, focused, and balanced after just a few sessions
This formulation is intended strictly for laboratory and scientific research use
The 30 mg figure is a vial strength , not a starting weekly dose
Ideal for all research studies
The heterogeneity of type 1 diabetes: implications for pathogenesis, prevention, and treatment2024 Diabetes, Diabetes Care, and Diabetologia Expert Forum